Pyxis Oncology, Inc. (PYXS): Price and Financial Metrics


Pyxis Oncology, Inc. (PYXS): $1.59

-0.01 (-0.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PYXS to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

PYXS Stock Price Chart Interactive Chart >

Price chart for PYXS

PYXS Price/Volume Stats

Current price $1.59 52-week high $9.87
Prev. close $1.60 52-week low $1.10
Day low $1.59 Volume 10,316
Day high $1.65 Avg. volume 39,961
50-day MA $1.38 Dividend yield N/A
200-day MA $2.14 Market Cap 55.80M

Pyxis Oncology, Inc. (PYXS) Company Bio


Pyxis Oncology, Inc., a preclinical stage biotechnology company, engages in the development of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies to treat cancers. Its preclinical products pipeline includes PYX-201, a site-specific investigational ADC targeting onco-fetal fibronectin extradomain-B for the treatment of non-small cell lung cancer; PYX-202, a site-specific investigational ADC targeting delta like non-canonical notch ligand 1 to treat small cell lung cancer, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational site-specific ADC targeting CD123 for the treatment of acute myeloid leukemia and other blood cancers. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.


PYXS Latest News Stream


Event/Time News Detail
Loading, please wait...

PYXS Latest Social Stream


Loading social stream, please wait...

View Full PYXS Social Stream

Latest PYXS News From Around the Web

Below are the latest news stories about PYXIS ONCOLOGY INC that investors may wish to consider to help them evaluate PYXS as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

The biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today!

William White on InvestorPlace | December 5, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning!

William White on InvestorPlace | December 1, 2022

How is PYXS’s stock performing after recent trades?

In the current trading session, Pyxis Oncology Inc.’s (PYXS) stock is trading at the price of $1.48, a gain of 2.07% over last night’s close. So, the stock is trading at a price that is -88.56% less than its 52-week high of $12.94 and 10.45% better than its 52-week low of $1.34. Based on the […]

US Post News | December 1, 2022

CTXR, SCYX and TOPS are among pre market gainers

Ra Medical Systems (RMED) +22%. Okta (OKTA) +17% Q3earnings call releasePyxis Oncology (PYXS) +14% gains on FDA nod to start two Phase 1 trials for cancer drugs.SOBR Safe…

Seeking Alpha | December 1, 2022

PYXS stock gains on FDA nod to start two Phase 1 trials for cancer drugs (NASDAQ:PYXS)

Development-stage biotech Pyxis Oncology (PYXS) announced Thursday that the FDA cleared two of its Investigational New Drug ((IND)) applications permitting the company to start Phase…

Seeking Alpha | December 1, 2022

Read More 'PYXS' Stories Here

PYXS Price Returns

1-mo 26.19%
3-mo -15.43%
6-mo -40.00%
1-year -81.32%
3-year N/A
5-year N/A
YTD 18.66%
2022 -87.78%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8104 seconds.